Insights on China Healthcare Policy: New Intensive Procurement Policy for High-Value Medical Devices
The article analyzed potential impact of China's new intensive procurement policy on high-value medical devices. If interested in investing China...
238 Views
China Healthcare Weekly (Oct.23)
This article summarized important new China healthcare policy released last week, major industry viewpoints, company news and market review for...
234 Views
Varian-Siemens Deal: DAX Promotion on the Cards for the Acquirer
This is the largest healthcare sector M&A Deal announced so far in 2020. Earlier this year, in March, Thermo Fisher Scientific Inc (TMO US)...
487 Views
Venus Medtech IPO: Fairly Valued and More Room for Share Price to Grow
In our previous insight on Venus Medtech IPO Venus Medtech IPO: First Mover Advantage in Chinese TAVR Market to Support Growth , we discussed the...
533 Views
Venus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers
Venus Medtech, a China Hangzhou-based transcatheter heart valve medical device player, is looking to raise up to USD 300 million via a listing in...
675 Views